Stockscreener 앱 받기
37.37
3.29%
-1.27
시간 외 거래:
37.37
전일 마감가:
$38.64
열려 있는:
$38.525
하루 거래량:
629.07K
Relative Volume:
1.41
시가총액:
$1.07B
수익:
-
순이익/손실:
$-69.47M
주가수익비율:
-6.6764
EPS:
-5.5973
순현금흐름:
$-73.92M
1주 성능:
-3.04%
1개월 성능:
+18.18%
6개월 성능:
+75.53%
1년 성능:
+69.86%
1일 변동 폭
$36.81
$39.50
1주일 범위
$36.81
$41.26
52주 변동 폭
$16.54
$41.70
Lenz Therapeutics Inc Stock (LENZ) Company Profile
명칭
Lenz Therapeutics Inc
전화
858-925-7000
주소
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
LENZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
37.37 | 1.10B | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-14 | 재개 | Piper Sandler | Overweight |
| 2025-03-18 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2024-04-15 | 개시 | William Blair | Outperform |
| 2024-04-10 | 개시 | Citigroup | Buy |
| 2024-03-27 | 개시 | Piper Sandler | Overweight |
| 2023-02-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2023-01-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-06 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-14 | 개시 | BTIG Research | Buy |
| 2022-03-22 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 개시 | Morgan Stanley | Overweight |
| 2021-07-20 | 개시 | SVB Leerink | Outperform |
모두보기
Lenz Therapeutics Inc 주식(LENZ)의 최신 뉴스
How institutional ownership impacts LENZ Therapeutics Inc. stock2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Should you hold or exit LENZ Therapeutics Inc. nowJuly 2025 Macro Moves & Community Supported Trade Ideas - Newser
Why LENZ Therapeutics Inc. is moving today2025 EndofYear Setup & Safe Entry Zone Tips - Newser
LENZ Therapeutics Inc. stock outlook for YEAR2025 Valuation Update & Reliable Volume Spike Trade Alerts - Newser
Has LENZ Therapeutics Inc. found a price floor2025 Market Outlook & Momentum Based Trading Ideas - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysisShort Setup & Capital Efficient Trade Techniques - Newser
What the charts say about LENZ Therapeutics Inc. todayJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Using data tools to time your LENZ Therapeutics Inc. exitPortfolio Gains Report & Consistent Profit Trade Alerts - Newser
What makes LENZ Therapeutics Inc. stock price move sharplyPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Detecting support and resistance levels for LENZ Therapeutics Inc.July 2025 Summary & Low Risk High Reward Ideas - Newser
Trend analysis for LENZ Therapeutics Inc. this weekWeekly Stock Report & Safe Swing Trade Setups - Newser
Real time breakdown of LENZ Therapeutics Inc. stock performanceGlobal Markets & Stepwise Trade Execution Plans - Newser
Using data models to predict LENZ Therapeutics Inc. stock movementWeekly Gains Report & Capital Efficiency Focused Strategies - Newser
Investors Hope for Bounce in LENZ Therapeutics Inc. After Selloff getLinesFromResByArray error: size == 0 - sisain.net
Full technical analysis of LENZ Therapeutics Inc. stock2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
LENZ Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Update & High Yield Stock Recommendations - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio chartsWeekly Risk Report & Fast Exit Strategy with Risk Control - Newser
How to build a dashboard for LENZ Therapeutics Inc. stock2025 Retail Activity & Low Risk Entry Point Tips - Newser
What MACD and RSI say about LENZ Therapeutics Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
How to manage a losing position in LENZ Therapeutics Inc.Trade Risk Assessment & AI Powered Market Entry Ideas - Newser
LENZ Therapeutics to Present VIZZ at Upcoming Investor and Medical Conferences. - AInvest
First FDA-Approved Aceclidine Eye Drops: LENZ Therapeutics to Present VIZZ Data at Multiple Fall Conferences - Stock Titan
How much upside does LENZ Therapeutics Inc. haveTrade Signal Summary & Daily Stock Trend Watchlist - sundaytimes.kr
Will LENZ Therapeutics Inc. stock recover after recent drop2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Will LENZ Therapeutics Inc. benefit from macro trendsForecast Cut & Growth-Oriented Investment Plans - Newser
Has LENZ Therapeutics Inc. Stock Ever Crashed Historical Volatility Review2025 Risk Factors & Growth Focused Investment Plans - Newser
LENZ Therapeutics stock price target raised to $56 from $48 at H.C. Wainwright By Investing.com - Investing.com Nigeria
LENZ Therapeutics stock price target raised to $56 from $48 at H.C. Wainwright - Investing.com
LENZ Therapeutics Inc. Stocks Attracting Dip BuyersJuly 2025 Rallies & High Conviction Buy Zone Alerts - 더경남뉴스
LENZ Therapeutics' Vizz Approval Sets Stage for Commercial Potential - AInvest
Will FDA Approval of Vizz Eye Drops Change LENZ Therapeutics' (LENZ) Narrative? - Yahoo Finance
What high frequency data says about LENZ Therapeutics Inc.2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
News impact scoring models applied to LENZ Therapeutics Inc.Market Sentiment Report & Real-Time Buy Signal Notifications - Newser
Does LENZ Therapeutics Inc. qualify in momentum factor screeningPortfolio Return Summary & Short-Term Trading Alerts - Newser
Lenz Therapeutics Inc (LENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lenz Therapeutics Inc 주식 (LENZ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
47,443 |
1,850,891 |
1,274,197 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
26,161 |
1,050,392 |
1,374,059 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
25,818 |
1,020,888 |
924,175 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
23,368 |
911,655 |
900,807 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
12,885 |
517,356 |
949,993 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
145,051 |
5,729,514 |
1,430,848 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
69,949 |
2,762,986 |
977,963 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
30,628 |
1,181,049 |
1,400,220 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
15,085 |
581,694 |
962,878 |
| Versant Venture Capital VI, L. | 10% Owner |
Jul 10 '25 |
Sale |
34.00 |
191,376 |
6,506,784 |
1,575,899 |
0.98%
8.06%
자본화:
|
볼륨(24시간):